Nurse CPD Education
Information for you and your patients
Liver disease now affects up to 3 of every 10 Australian adults. Primary liver cancer is the most rapidly rising cause of cancer death. Health promotion, prevention, proactive case-finding, early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. Learn how to identify, manage and support your patients with liver disease.
Patient information
This website is full of practical, evidence based information for your patients. It is written by clinical experts, with nurse and patient input and prepared at an accessible reading level. Please direct patients to the Your Liver tab for disease information and the Living Well tab for information about living well with liver disease at all stages.
You can also order a range of resources or an in-service from one of our specialist nurses for your clinic or practice here.
Our FREE nurse-led support line is available from 8:00am – 6:00pm (AEST). Your patients can call 1800 841 118 to speak to a friendly, expert liver nurse for advice and support.
Free, online CPD education on all aspects of patient care in liver disease
Whilst initially developed for GPs, this education is endorsed by the Australasian Hepatology Association (AHA) as education relevant for their members. The course is available free of charge as a full 7 hour Advanced Course: The Rising Health Threat of Liver Disease. When you complete the course, you will receive a Certificate of Completion.
The rising health threat of liver disease: What GPs can do to prevent premature mortality
Advanced Course | Hours: 7 | EA: 5 | MO: 0 | RP: 2
Liver disease now affects up to 3 of every 10 Australian adults. Primary liver cancer is the most rapidly rising cause of cancer death. Health promotion, prevention, proactive case-finding, early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. Learn how to identify, manage and support your patients with liver disease.
Liver disease overview: What GPs need to know
Short Course | Hours: 2 | EA: 1.5 | MO: 0 | RP: 0.5
Liver disease now affects up to 3 of every 10 Australian adults. This module provides an overview of liver disease and looks at what GPs need to know about assessing and managing these conditions in primary care.
Metabolic-associated fatty liver disease (MAFLD)
Short Course | Hours: 2 | EA: 1.5 | MO: 0 | RP: 0.5
GPs must be able to assess the severity of metabolic-associated fatty liver disease in primary care and guide their patients’ future management to determine the need for referral to secondary care or management in primary care. This course will help GPs and nurses to understand the additional steps that are required to ensure that the underlying cause is determined and addressed.
Management of patients with advanced liver disease: The role of the general practitioner
Short Course | Hours: 2 | EA: 1.5 | MO: 0 | RP: 0.5
Early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. This course will show GPs and nurses how cirrhosis is identified, how to prevent and manage the complications of cirrhosis, and the important role they play in the integrated care of the patient with cirrhosis.
Identifying and managing rarer liver diseases: What GPs should be aware of
Short Course | Hours: 1 | EA: 1
GPs play an important role in the early identification, evaluation and monitoring of patients with rarer liver diseases. This module will provide an overview of the rarer liver diseases and highlight the red flags that indicate urgent specialist review or hospitalisation.
An Introduction to the Nursing Care and Management of Patients with Advanced Liver Disease.
The AHA runs a full day training course An Introduction to the Nursing Care and Management of Patients with Advanced Liver Disease. It is designed specifically for Registered Nurses who come into contact with patients who have advanced liver disease and cancer.
